"FDA and EMA release collaborative AI framework for drug development" was originally created and published by Clinical Trials ...

In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...

The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...

SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Top of the list is that AIs must be human-centric by design and align with ethical values. They must be developed using a ...

SAN FRANCISCO, Jan 13 () - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug ...

EMA and FDA define ten principles for AI use in medicines – in response to growing pressure from the industry.

Teva has penned a second pact with Royalty Pharma, this time securing up to $500 million to support the clinical development ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the Research and ...

From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA. Dr. Ge Michael, President and CEO of Sichuan Kelun-Biotech Biopharmaceutical ...

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...